SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

GSK and Moderna Settle Patent Dispute Over COVID and RSV Shots

The companies settled GSK lawsuits alleging that Moderna’s Spikevax and mNEXSPIKE COVID-19 vaccines and mResvia RSV shot infringed its patents.

GSKMRNA

By Blake BrittainBritish drugmaker GSK LSE:GSK has settled lawsuits that accused Moderna's NASDAQ:MRNA COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, the companies said on Friday.

Related stories